Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEXGEL, INC.

2.53
+0.0000
Volume:13.38K
Turnover:33.83K
Market Cap:19.36M
PE:-5.02
High:2.75
Open:2.61
Low:2.45
Close:2.53
Loading ...

Company Profile

Company Name:
NEXGEL, INC.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
19
Office Location:
2150 Cabot Boulevard West,Suite B,Langhorne,Pennsylvania,United States
Zip Code:
19047
Fax:
- -
Introduction:
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Directors

Name
Position
Adam Levy
Chief Executive Officer, President and Director
David Stefansky
Director
Jerome B. Zeldis
Director
Miranda J. Toledano
Director
Nachum Stein
Director
Steven Glassman
Director
Yaakov Spinrad
Director

Shareholders

Name
Position
Adam Levy
Chief Executive Officer, President and Director
Adam E. Drapczuk III
Chief Financial Officer